Abstract:Background: Dexmedetomidine is known for its selective action on α2-adrenoceptor sites and is recognized for its neuroprotective capabilities. It can improve postoperative cognitive function. Commonly used anesthetics, such as sevoflurane and propofol, have been reported to affect postoperative cognitive function. Therefore, it could be valuable to explore dexmedetomidine-led anesthesia strategy. This study was designed to assess the performance, safety, and effective infusion rate in anesthesia maintenance, to explore a feasible dexmedetomidine-led anesthesia maintenance protocol, and to provide a foundation for potential combined anesthesia. Methods: Thirty patients aged 18-60 years, classified as ASA I or II, undergoing abdominal surgery were involved. The anesthesia maintenance was achieved with dexmedetomidine, remifentanil and rocuronium. Dixon up-and-down sequential methodology was utilized to ascertain the ED50 of dexmedetomidine for maintaining Patient State Index (PSI) 25-40 (depth of stage III anesthesia). Intraoperative HR, BP and depth of anesthesia were monitored and controlled. The wake-up time from anesthesia, the incidence of intraoperative awareness and postoperative delirium, and the patients' satisfaction were assessed. Results: The results indicated that dexmedetomidine-led anesthesia could maintain the depth of stage III anesthesia during abdominal surgery. The ED50 and ED95 of dexmedetomidine infusion rates during anesthesia maintenance were 2.298 μg/kg·h (95%CI: 2.190-2.404 μg/kg·h) and 3.765 μg/kg·h (95%CI: 3.550-4.050 μg/kg·h). Continuous infusion of dexmedetomidine and 0.1-0.3 μg/kg·min remifentanil could maintain PSI 25-40, and provide appropriate anesthesia depth for abdominal surgery. Perioperative bradycardia and hypertension could be rapidly corrected with atropine and nitroglycerin. The median wake-up time after anesthesia was 4.8 min, the perioperative maximum HR had significant correlation with wake-up time and intraoperative dexmedetomidine dose. No intraoperative awareness and postoperative delirium occurred; the patients were satisfied with dexmedetomidine-led anesthesia. Conclusions: dexmedetomidine-led strategy could maintain stable depth of anesthesia throughout surgery, and the ED50 of dexmedetomidine infusion rates was 2.298 μg/kg·h. Intraoperative HR, BP and depth of anesthesia require monitoring, the bradycardia and hypertension could be rapidly corrected.

Application of Dexmedetomidine as An Adjunct to General Anesthesia for Lung Cancer Radical Operations through Thoracotomy Approach

Application Effect of Dexmedetomidine and Dezocine in Patients Undergoing Lung Cancer Surgery under General Anesthesia and Analysis of Their Roles in Recovery Time and Cognitive Function

Effect Of Dexmedetomidine On Perioperative Inflammation And Lung Protection In Elderly Patients Undergoing Radical Resection Of Lung Cancer

Effect of dexmedetomidine on postoperative nausea and vomiting in female patients undergoing radical thoracoscopic lung cancer resection

Preliminary study of appling dexmedetomidine in patients undergoing general thoracic surgery

Dexmedetomidine attenuates inflammatory response and chronic pain following video-assisted thoracoscopic surgery for lung cancer

Application of dexmedetomidine in lumbar vertebral surgery

[Dexmedetomidine improves function of lung oxygenation in patients with moderate chronic obstructive pulmonary disease underwent lung cancer surgery].

Application of Dexmedetomidine Combined with Sufentanil in Colon Cancer Resection and Its Effect on Immune and Coagulation Function of Patients.

Combined use of dexmedetomidine and nalbuphine in laparoscopic radical gastrectomy for gastric cancer

Auxiliary application of dexmedetomidine hydrochloride in patients undergoing endoscopic nasal surgery under local anesthesia

The pulmonary protection of dexmedetomidine in combination with parecoxib in patients undergoing thoracotomy during one-lung ventilation

Effects of dexmedetomidine on general anesthesia with closed-loop target controlled infusion of propofol (Xi’an 710004)

The Efficacy of Dexmedetomidine Combined with Sufentanil for Postoperative Analgesia and the Effect on Immune Function and Pulmonary Complications in Patients Undergoing Operation of Lung Cancer

The Application of Dexmedetomidine in Pediatric Tracheobronchial Foreign Body Removal Surgery

Impacts of Dexmedetomidine on sedative effects of fentanyl for percutaneous tracheotomy in laryngeal carcinoma

Clinical Application of Dexmedetomidine as an Adjunct to Local Anesthesia in Radical Mastoidectomy

The feasibility of dexmedetomidine-led anesthesia maintenance strategy during major abdominal surgery

Effect of Dexmedetomidine or Epidural Blockade Combined with General Anesthesia on Perioperative Inflammatory Cytokines in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery

Impact of dexmedetomidine-assisted anesthesia in elderly patients undergoing radical resection of colon cancer

Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery